Design Therapeutics, Inc.
DSGN
$14.83
$0.443.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -70.80M | -69.71M | -69.79M | -67.45M | -63.49M |
| Total Depreciation and Amortization | 619.00K | 620.00K | 622.00K | 615.00K | 613.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.50M | 13.07M | 11.70M | 10.82M | 9.66M |
| Change in Net Operating Assets | 1.59M | 2.02M | 3.11M | 3.76M | 2.58M |
| Cash from Operations | -55.08M | -54.00M | -54.36M | -52.25M | -50.64M |
| Capital Expenditure | -55.00K | -121.00K | -193.00K | -159.00K | -143.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.45M | 7.58M | 23.11M | 36.49M | 24.14M |
| Cash from Investing | 2.39M | 7.45M | 22.91M | 36.33M | 23.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 45.89M | 45.65M | 25.74M | 684.00K | 648.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.89M | 45.65M | 25.74M | 684.00K | 648.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.80M | -897.00K | -5.71M | -15.24M | -26.00M |